In pancreatic cancer, the activation of the KRAS/ERK pathway upregulated protein interacting with never in mitosis A1 (PIN1), which synergized with c-Myc and NRF2 to maintain redox balance and promote cell survival [71]. Here, NFE2L2 is linked to pancreatic neoplasm.